WallStSmart

Dolby Laboratories (DLB)vsRelx PLC ADR (RELX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Relx PLC ADR generates 616% more annual revenue ($9.59B vs $1.34B). RELX leads profitability with a 21.5% profit margin vs 18.0%. RELX appears more attractively valued with a PEG of 1.36. RELX earns a higher WallStSmart Score of 62/100 (C+).

DLB

Hold

48

out of 100

Grade: D+

Growth: 2.7Profit: 7.0Value: 7.3Quality: 7.3
Piotroski: 3/9Altman Z: 4.85

RELX

Buy

62

out of 100

Grade: C+

Growth: 5.3Profit: 9.0Value: 10.0Quality: 3.8
Piotroski: 4/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

DLBSignificantly Overvalued (-311.3%)

Margin of Safety

-311.3%

Fair Value

$16.80

Current Price

$58.64

$41.84 premium

UndervaluedFair: $16.80Overvalued
RELXUndervalued (+43.1%)

Margin of Safety

+43.1%

Fair Value

$50.66

Current Price

$32.47

$18.19 discount

UndervaluedFair: $50.66Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DLB3 strengths · Avg: 8.7/10
Altman Z-ScoreHealth
4.8510/10

Safe zone — low bankruptcy risk

Price/BookValuation
2.2x8/10

Reasonable price relative to book value

Operating MarginProfitability
20.9%8/10

Strong operational efficiency at 20.9%

RELX5 strengths · Avg: 9.2/10
Return on EquityProfitability
70.5%10/10

Every $100 of equity generates 71 in profit

Operating MarginProfitability
31.4%10/10

Strong operational efficiency at 31.4%

Market CapQuality
$60.80B9/10

Large-cap with strong market position

Profit MarginProfitability
21.5%9/10

Keeps 22 of every $100 in revenue as profit

Free Cash FlowQuality
$1.48B8/10

Generating 1.5B in free cash flow

Areas to Watch

DLB4 concerns · Avg: 2.8/10
PEG RatioValuation
2.084/10

Expensive relative to growth rate

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Revenue GrowthGrowth
-2.9%2/10

Revenue declined 2.9%

EPS GrowthGrowth
-21.4%2/10

Earnings declined 21.4%

RELX3 concerns · Avg: 3.0/10
Price/BookValuation
18.8x4/10

Trading at 18.8x book value

Revenue GrowthGrowth
1.2%4/10

1.2% revenue growth

Debt/EquityHealth
3.101/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : DLB

The strongest argument for DLB centers on Altman Z-Score, Price/Book, Operating Margin. Profitability is solid with margins at 18.0% and operating margin at 20.9%.

Bull Case : RELX

The strongest argument for RELX centers on Return on Equity, Operating Margin, Market Cap. Profitability is solid with margins at 21.5% and operating margin at 31.4%. PEG of 1.36 suggests the stock is reasonably priced for its growth.

Bear Case : DLB

The primary concerns for DLB are PEG Ratio, Piotroski F-Score, Revenue Growth.

Bear Case : RELX

The primary concerns for RELX are Price/Book, Revenue Growth, Debt/Equity. Debt-to-equity of 3.10 is elevated, increasing financial risk.

Key Dynamics to Monitor

DLB profiles as a declining stock while RELX is a value play — different risk/reward profiles.

DLB carries more volatility with a beta of 0.84 — expect wider price swings.

RELX is growing revenue faster at 1.2% — sustainability is the question.

RELX generates stronger free cash flow (1.5B), providing more financial flexibility.

Bottom Line

RELX scores higher overall (62/100 vs 48/100), backed by strong 21.5% margins. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Dolby Laboratories

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

Dolby Laboratories, Inc. creates imaging and audio technologies that transform entertainment and communications in the theater, home, work, and mobile devices. The company is headquartered in San Francisco, California.

Relx PLC ADR

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

RELX PLC provides information-based decision-making and analysis tools for professional and commercial clients in North America, Europe, and internationally. The company is headquartered in London, the United Kingdom.

Visit Website →

Want to dig deeper into these stocks?